Physician
Pediatric Hematology & Oncology
Dr. Sandra Meech, MD
|
|
Give Review
Sandra Meech works in the field of Pediatric Hematology & Oncology. She graduated from University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is one of the top medical schools in the US. University of Colorado Denver School of Medicine is ranked 35 in research and 8 in primary care medicine Sandra Meech is a published doctor and has 16 publications published. The lastest was: 'Adenoviral-mediated gene transfer in lymphocytes.'
Publications
- Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: comparison with primary cutaneous anaplastic large cell lymphoma.
- Regulation of Fas-mediated apoptosis by N-ras in melanoma.
- Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma.
- Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
- Advanced small cell carcinoma of the ovary in a pediatric patient with long-term survival and review of the literature.
- Combined computed tomography-guided radiofrequency ablation and brachytherapy in a child with multiple recurrences of Wilms' tumor.
- Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung...
- Opportunities and challenges in the development of experimental drug combinations for cancer.
- Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells.
- Transplantation of cells and tissues expressing Fas ligand.
- Reversible resistance to apoptosis in cutaneous T cell lymphoma.
- Adenoviral-mediated gene transfer in lymphocytes.
- Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion.
- A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.
- Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis.
Schools
UNIVERSITY OF COLORADO AT DENVER
University Colo School Med
Chldns Hospital
Chldns Hospital University Colo School Med
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
University of Colorado -
University of Colorado Denver School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Peter E. Manley, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel A. Altura, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anjulika Chawla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Preeya L. Desh, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine M. Heske, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradley D. Denardo, MD
This Doctor is OpenDoctor Recommended.
|